Clinical Trials
2 trialsNCT04862650 2026-02-10
Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Ohio State University Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT00003327 2008-07-24
Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Unknown